Study on OsseoSpeed™ TX Implants in the Upper Jaw in a Chinese Population

Partially Edentulous Jaw Clinical Trial

Official title:

An Open, Prospective, Multi-center Study to Evaluate the OsseoSpeed™ TX Implant With an Early Loading Protocol in Patients With Tooth Loss in the Posterior Maxilla. A 3-years Follow-up Study.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01389245
• Other study ID #: CHN-0001
• Status: Completed
• Phase: N/A
• Start date: June 2011
• Est. completion date: September 2017

Study information

• Verified date: April 2020
• Source: Dentsply Sirona Implants
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to investigate the clinical efficacy of OsseoSpeed™ TX implants in a Chinese population by evaluation of marginal bone level alteration, implant stability and implant survival in the posterior maxilla up to 3 years after loading. Hypothesis: Early loading of the posterior maxilla is a safe and predictable procedure.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 42
• Est. completion date: September 2017
• Est. primary completion date: July 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 75 Years

Eligibility

Inclusion criteria:

1. Provision of informed consent

2. Aged 20-75 years at enrollment

3. History of edentulism in the posterior maxilla, Kennedy classes I or II, of at least four months. Last natural tooth in function is canine or first bicuspid.

4. Neighboring tooth to the planned bridge must have natural root.

5. Presence of natural teeth, partial prosthesis and/or implants in the opposite jaw in contact with the planned bridge.

6. Deemed by the investigator to have adequate bone height and a bone width of minimum 5.5 mm.

7. Deemed by the investigator as likely to present an initially stable implant situation

Exclusion criteria:

1. Unlikely to be able to comply with study procedures, as judged by the investigator

2. Earlier graft procedures in the study area

3. Current need for pre-surgical bone or soft tissue augmentation in the planned implant area.

4. Uncontrolled pathologic processes in the oral cavity

5. Known or suspected current malignancy

6. History of radiation therapy in the head and neck region

7. History of chemotherapy within 5 years prior to surgery

8. Systemic or local disease or condition that could compromise post-operative healing and/or osseointegration

9. Uncontrolled diabetes mellitus

10. Corticosteroids or any other medication that could influence post-operative healing and/or osseointegration

11. Smoking more than 10 cigarettes/day

12. Present alcohol and/or drug abuse

13. Involvement in the planning and conduct of the study (applies to both Astra Tech staff and staff at the study site)

14. Previous enrollment in the present study.

15. Simultaneous participation in another clinical study or participation in a clinical study during the last 6 months.

16. Subjects that are unable to give informed consent

Related Conditions & MeSH terms

• Jaw, Edentulous
• Partially Edentulous Jaw

Intervention

Device:
• OsseoSpeed™ TX
OsseoSpeed™ TX implants of lengths 8-17 mm

Locations

Country	Name	City	State
China	Capital Medical University School of Stomatology, Centre of Oral Implantation	Beijing
China	Guanghua School of Stomatology, Sun Yat-Sen University	Guangzhou
China	Department of Prosthodontics, Nanjing Stomatology Hospital, Nanjing University	Nanjing

Sponsors (1)

Lead Sponsor	Collaborator
Dentsply Sirona Implants

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Marginal Bone Level Alteration	Marginal bone level determined from radiographs and expressed as the distance from a reference point on the implant to the most coronal bone-to-implant contact on the mesial and distal aspect of the implant. Marginal bone level expressed in millimeters at the 3-year follow-up visit compared to values obtained at delivery of permanent restoration i.e. loading (baseline).	Measured at implant loading and at the 3-year follow-up after implant loading.
Secondary	Number of Stable Implants	Implant stability evaluated clinically/manually (recorded as stable yes/no).	Measured at the 3-year follow-up after implant loading.
Secondary	Evaluation of the Periimplant Mucosa Condition - By Assessment of PPD	Condition of the periimplant mucosa by assessment of probing pocket depth (PPD).; Change in pocket depth expressed in millimeters at the 3-year follow-up visit, compared to values obtained at delivery of permanent restoration, i.e. loading (baseline).; Negative value = increased pocket depth.	Measured at the 3-year follow-up after implant loading.
Secondary	Number of Survived Implants	Implant survival rate evaluated by clinically and radiographically, counting the number of implants remaining in function.	Measured at the 3-year follow-up after implant loading.
Secondary	Presence of Plaque	Occurence of plaque around the study implant. Presented as number of implants that show presence of plaque at time of the 3-year follow-up visit after implant loading.	Measured at the 3-year follow-up after implant loading.